Last week, three PhD plant biologists announced the close of a $1.25 million seed round to fund their company Dewey Scientific, which seeks to bring quality and consistent cannabis to market.
The new infusion of funding will accelerate the company’s genomic analysis, tailored breeding for regional environmental adaptation, and terpene diagnostic services for cannabis cultivators.
The Washington-based agtech company launched in 2018, and has since acquired a facility that includes biological labs and greenhouses.
Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.
Dewey Scientific is also developing its IP portfolio to help cultivators guide cannabis breeding decisions.
“We’re driven to provide real, tangible results working at the intersection of classical breeding and molecular biology that produce consistent cannabis for consumers and increase crop yields and resiliency for cultivators,” said CEO Jordan Zager. “Our deep scientific knowledge is matched by our passion as stewards of the future of this vital crop for farmers, consumers, and the economy.”
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!